Please enter your credentials to continue.
Asia
Africa
Australia
China
Europe
Canada
Middle East
United Kingdom
United States
>>
The FDA issued a rare refusal-to-file letter for Moderna’s mRNA-1010 flu shot over comparator concerns. Moderna calls the move “inconsiste...
Eikon Therapeutics raises $381M in a major biotech IPO, marking 2026's third successful public offering for the sector amid renewed investor optimism....
The FDA suspends two Regenxbio gene therapy trials over safety concerns after a study participant developed a brain tumor. The U.S. Food and Drug Adm...
Johnson & Johnson projects it can achieve $100 billion in annual sales, driven by strong growth in its oncology and immunology pharmaceutical port...
Vaccine manufacturers are bracing for impact as Health Secretary Kennedy's anti-establishment rhetoric transforms into hard-line policy and aggressive...